These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29405886)

  • 1. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.
    Trad KS; Barnes WE; Prevou ER; Simoni G; Steffen JA; Shughoury AB; Raza M; Heise JA; Fox MA; Mavrelis PG
    Surg Innov; 2018 Apr; 25(2):149-157. PubMed ID: 29405886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial.
    Trad KS; Barnes WE; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Turgeon DG; Fox MA
    Surg Innov; 2015 Feb; 22(1):26-40. PubMed ID: 24756976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.
    Trad KS; Fox MA; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Barnes WE
    Surg Endosc; 2017 Jun; 31(6):2498-2508. PubMed ID: 27655380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.
    Janu P; Shughoury AB; Venkat K; Hurwich D; Galouzis T; Siatras J; Streeter D; Korman K; Mavrelis G; Mavrelis P
    Surg Innov; 2019 Dec; 26(6):675-686. PubMed ID: 31431138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.
    Testoni PA; Testoni S; Mazzoleni G; Vailati C; Passaretti S
    Surg Endosc; 2015 Sep; 29(9):2770-80. PubMed ID: 25480624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms.
    Trad KS; Turgeon DG; Deljkich E
    Surg Endosc; 2012 Mar; 26(3):650-60. PubMed ID: 21959689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year results of a multicenter prospective study of transoral incisionless fundoplication.
    Muls V; Eckardt AJ; Marchese M; Bastens B; Buset M; Devière J; Louis H; Rajan A; Daniel MA; Costamagna G
    Surg Innov; 2013 Aug; 20(4):321-30. PubMed ID: 22968006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease.
    Bell RC; Freeman KD
    Surg Endosc; 2011 Jun; 25(6):1975-84. PubMed ID: 21140170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of Laryngopharyngeal Symptoms to Transoral Incisionless Fundoplication in Patients with Refractory Proven Gastroesophageal Reflux.
    Snow GE; Dbouk M; Akst LM; Ihde G; Zarnegar R; Janu P; Murray M; Eskarous H; Sohagia A; Dhar SI; Irene Canto M
    Ann Otol Rhinol Laryngol; 2022 Jun; 131(6):662-670. PubMed ID: 34378427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial.
    Hunter JG; Kahrilas PJ; Bell RC; Wilson EB; Trad KS; Dolan JP; Perry KA; Oelschlager BK; Soper NJ; Snyder BE; Burch MA; Melvin WS; Reavis KM; Turgeon DG; Hungness ES; Diggs BS
    Gastroenterology; 2015 Feb; 148(2):324-333.e5. PubMed ID: 25448925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX.
    Cadière GB; Van Sante N; Graves JE; Gawlicka AK; Rajan A
    Surg Endosc; 2009 May; 23(5):957-64. PubMed ID: 19288158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease.
    Ihde GM; Besancon K; Deljkich E
    Am J Surg; 2011 Dec; 202(6):740-6; discussion 746-7. PubMed ID: 22014853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.
    Bell RC; Mavrelis PG; Barnes WE; Dargis D; Carter BJ; Hoddinott KM; Sewell RW; Trad KS; DaCosta Gill B; Ihde GM
    J Am Coll Surg; 2012 Dec; 215(6):794-809. PubMed ID: 22939637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis.
    McCarty TR; Itidiare M; Njei B; Rustagi T
    Endoscopy; 2018 Jul; 50(7):708-725. PubMed ID: 29625507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
    Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
    Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study.
    Cadière GB; Buset M; Muls V; Rajan A; Rösch T; Eckardt AJ; Weerts J; Bastens B; Costamagna G; Marchese M; Louis H; Mana F; Sermon F; Gawlicka AK; Daniel MA; Devière J
    World J Surg; 2008 Aug; 32(8):1676-88. PubMed ID: 18443855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and patient satisfaction of single-session transoral incisionless fundoplication and laparoscopic hernia repair.
    Gisi C; Wang K; Khan F; Reicher S; Hou L; Fuller C; Sattler J; Eysselein V
    Surg Endosc; 2021 Feb; 35(2):921-927. PubMed ID: 32691205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of second-generation transoral incisionless fundoplication on atypical GERD symptoms: a systematic review and meta-analysis.
    Haseeb M; Brown JRG; Hayat U; Bay C; Bain PA; Jirapinyo P; Thompson CC
    Gastrointest Endosc; 2023 Mar; 97(3):394-406.e2. PubMed ID: 36402203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.